Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Top Cited Papers
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 27 (3) , 165-176
- https://doi.org/10.1053/ctrv.2000.0210
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problemCancer Treatment Reviews, 2000
- Use of bisphosphonates for the treatment of bone metastasis in experimental animal modelsCancer Treatment Reviews, 1999
- A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer PatientsJournal of Bone and Mineral Research, 1999
- A randomized trial of the effect of clodronate on skeletal morbidity in multiple myelomaBritish Journal of Haematology, 1998
- Efficacy of Pamidronate in Breast Cancer with Bone Metastases: A Randomized Double-Blind Placebo Controlled Multicenter StudyActa Oncologica, 1996
- A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneEuropean Journal of Cancer and Clinical Oncology, 1991
- Liver metastases from breast cancer: The relationship between clinical, biochemical and pathological features and survivalEuropean Journal of Cancer and Clinical Oncology, 1990
- Metastatic Disease in Long Bones A Proposed Scoring System for Diagnosing Impending Pathologic FracturesClinical Orthopaedics and Related Research, 1989
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Generalised Increase in Bone Resorption in Carcinoma of the ProstateBritish Journal of Urology, 1985